Zensei Pharmaceutical Co., Ltd., as a member of the Nipro Group, has been supporting patients’ health through our business activities as a CDMO (Contract Development and Manufacturing Organization) for oral solid dosage forms of pharmaceutical products.

We have established an integrated system covering from formulation development to commercial production at our two manufacturing sites located in Kishiwada City and Izumi City in the southern part of Osaka Prefecture.

For a company handling pharmaceuticals, the most important priority is “quality”. We never compromise on safety and reliability, regardless of any environmental changes and business expansions.

We are strengthening our quality management system through the use of digital technologies, including the implementation of MES (Manufacturing Execution System) and LIMS (Laboratory Information Management System). By doing so, we are committed to ensuring the reliability and transparency of our manufacturing data (thorough data integrity), while also fostering our “quality culture” through our enhanced internal education. All our employees work with a strong sense of ethics and responsibility.

Guided by our management philosophy of “Contributing to people’s health with MAGOKORO (sincerity)”, we recognize our mission as a life-related company. By continuing to stably supply our pharmaceutical products that can be used with confidence, we aim to remain a trusted and preferred partner for society.

We sincerely look forward to your continued support and guidance.

Toshiya Sawai
President and Representative Director